Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18 -80 years old. (2) Patients with non-valvular atrial fibrillation who were treated in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine and underwent catheter ablation for the first time. (3) Patients with persistent atrial fibrillation have atrial fibrillation lasting more than or equal to 3 months and less than or equal to 3 years. (4) Comply with the indications for catheter ablation of atrial fibrillation specified in China's 2023 Chinese guidelines for the diagnosis and treatment of atrial fibrillation. (5) Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Thrombosis or mass in the heart chamber. (2) Atrial fibrillation secondary to obvious reversible causes (including but not limited to hyperthyroidism/hypokalemia, etc.). (3) Clearly diagnosed cardiomyopathy (including but not limited to hypertrophic cardiomyopathy, dilated cardiomyopathy, etc.). (4) There are contraindications to the use of oral anticoagulant drugs. (5) Life expectancy is less than 1 year (such as advanced malignant tumors, advanced kidney disease, etc.). (6) History of heart-related surgery (such as coronary artery bypass/stent implantation/valve replacement, etc.). (7) Severe cardiac or macrovascular malformation. (8) Vulnerable groups, such as people with mental illness, cognitive impairment, critically ill patients, pregnant women, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate of mitral isthmus line block; | — |
Secondary
| Measure | Time frame |
|---|---|
| Left atrial voltage;Ablation time; | — |
Countries
China
Contacts
Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University